One-year follow-up of a TRASER clinical trial for the treatment of nasal telangiectasias

Elizabeth Geddes-Bruce; Selina S. Hamill; Christopher B. Zachary; Paul M. Friedman

doi:10.1002/lsm.22765

One-year follow-up of a TRASER clinical trial for the treatment of nasal telangiectasias

Elizabeth Geddes-Bruce, Selina S. Hamill, Christopher B. Zachary, Paul M. Friedman

Research output: Contribution to journal › Article › peer-review

5 Scopus citations

Abstract

OBJECTIVES: To evaluate the long-term efficacy of treating nasal telangiectasias with the TRASER device.

METHODS: Subjects from the TRASER efficacy analysis clinical trial were invited for a 1-year follow-up. Standardized photographs were taken to compare to baseline. The same clinical trial evaluator graded the subjects' current vessel clearance using the 5-point telangiectasia scale. The data was compiled and analyzed.

RESULTS: Of the subjects with available follow-up data, 44% maintained "complete vessel clearance," 44% dropped down one grade to "almost complete vessel clearance," and 11% dropped down to "moderately clear vessel clearance." All showed clinically significant improvement in nasal telangiectasias from baseline.

Original language	English (US)
Pages (from-to)	61-63
Number of pages	3
Journal	Lasers in Surgery and Medicine
Volume	50
Issue number	1
DOIs	https://doi.org/10.1002/lsm.22765
State	Published - Jan 2018

Keywords

TRASER
laser
telangiectasias
vessels

ASJC Scopus subject areas

Surgery
Dermatology

Divisions

Dermatology

Access to Document

10.1002/lsm.22765

Cite this

@article{d5e01443ffea41f795ebce6bf2e1da82,

title = "One-year follow-up of a TRASER clinical trial for the treatment of nasal telangiectasias",

abstract = "OBJECTIVES: To evaluate the long-term efficacy of treating nasal telangiectasias with the TRASER device.METHODS: Subjects from the TRASER efficacy analysis clinical trial were invited for a 1-year follow-up. Standardized photographs were taken to compare to baseline. The same clinical trial evaluator graded the subjects' current vessel clearance using the 5-point telangiectasia scale. The data was compiled and analyzed.RESULTS: Of the subjects with available follow-up data, 44\% maintained {"}complete vessel clearance,{"} 44\% dropped down one grade to {"}almost complete vessel clearance,{"} and 11\% dropped down to {"}moderately clear vessel clearance.{"} All showed clinically significant improvement in nasal telangiectasias from baseline.CONCLUSIONS: The TRASER effectively treats nasal telangiectasias with minimal to mild recurrence at 1-year follow-up. Lasers Surg. Med. 50:61-63, 2018. {\textcopyright} 2017 Wiley Periodicals, Inc.",

keywords = "TRASER, laser, telangiectasias, vessels",

author = "Elizabeth Geddes-Bruce and Hamill, \{Selina S.\} and Zachary, \{Christopher B.\} and Friedman, \{Paul M.\}",

note = "{\textcopyright} 2017 Wiley Periodicals, Inc.",

year = "2018",

month = jan,

doi = "10.1002/lsm.22765",

language = "English (US)",

volume = "50",

pages = "61--63",

journal = "Lasers in Surgery and Medicine",

issn = "0196-8092",

publisher = "Wiley",

number = "1",

}

TY - JOUR

T1 - One-year follow-up of a TRASER clinical trial for the treatment of nasal telangiectasias

AU - Geddes-Bruce, Elizabeth

AU - Hamill, Selina S.

AU - Zachary, Christopher B.

AU - Friedman, Paul M.

PY - 2018/1

Y1 - 2018/1

N2 - OBJECTIVES: To evaluate the long-term efficacy of treating nasal telangiectasias with the TRASER device.METHODS: Subjects from the TRASER efficacy analysis clinical trial were invited for a 1-year follow-up. Standardized photographs were taken to compare to baseline. The same clinical trial evaluator graded the subjects' current vessel clearance using the 5-point telangiectasia scale. The data was compiled and analyzed.RESULTS: Of the subjects with available follow-up data, 44% maintained "complete vessel clearance," 44% dropped down one grade to "almost complete vessel clearance," and 11% dropped down to "moderately clear vessel clearance." All showed clinically significant improvement in nasal telangiectasias from baseline.CONCLUSIONS: The TRASER effectively treats nasal telangiectasias with minimal to mild recurrence at 1-year follow-up. Lasers Surg. Med. 50:61-63, 2018. © 2017 Wiley Periodicals, Inc.

AB - OBJECTIVES: To evaluate the long-term efficacy of treating nasal telangiectasias with the TRASER device.METHODS: Subjects from the TRASER efficacy analysis clinical trial were invited for a 1-year follow-up. Standardized photographs were taken to compare to baseline. The same clinical trial evaluator graded the subjects' current vessel clearance using the 5-point telangiectasia scale. The data was compiled and analyzed.RESULTS: Of the subjects with available follow-up data, 44% maintained "complete vessel clearance," 44% dropped down one grade to "almost complete vessel clearance," and 11% dropped down to "moderately clear vessel clearance." All showed clinically significant improvement in nasal telangiectasias from baseline.CONCLUSIONS: The TRASER effectively treats nasal telangiectasias with minimal to mild recurrence at 1-year follow-up. Lasers Surg. Med. 50:61-63, 2018. © 2017 Wiley Periodicals, Inc.

KW - TRASER

KW - laser

KW - telangiectasias

KW - vessels

UR - https://www.scopus.com/pages/publications/85040771116

UR - https://www.scopus.com/inward/citedby.url?scp=85040771116&partnerID=8YFLogxK

U2 - 10.1002/lsm.22765

DO - 10.1002/lsm.22765

M3 - Article

C2 - 29171039

AN - SCOPUS:85040771116

SN - 0196-8092

VL - 50

SP - 61

EP - 63

JO - Lasers in Surgery and Medicine

JF - Lasers in Surgery and Medicine

IS - 1

ER -

One-year follow-up of a TRASER clinical trial for the treatment of nasal telangiectasias

Abstract

Keywords

ASJC Scopus subject areas

Divisions

Access to Document

Other files and links

Fingerprint

Cite this